Related Experiment Video

Updated: Jun 18, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Statins in prevention of repeat revascularization after percutaneous coronary intervention--a meta-analysis of

Zhi-Jiang Zhang1, Qi Cheng, Guo-Xin Jiang

  • 1Department of Epidemiology, School of Public Health, Shanghai Jiao Tong University, Shanghai, China. zhz232@gmail.com

Pharmacological Research
|November 20, 2009
PubMed

Insights

Statin therapy after percutaneous coronary intervention (PCI) significantly reduces repeat revascularization risk. Further research is needed to understand the mechanisms behind this benefit in cardiovascular patients.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Trials

Background:

  • Observational studies suggest statins reduce adverse events post-PCI.
  • Evidence from randomized clinical trials (RCTs) confirming these benefits is limited.
  • Understanding statin effects on specific outcomes is crucial for mechanistic studies.

Purpose of the Study:

  • To evaluate the impact of post-procedural statin therapy on clinical outcomes after coronary angioplasty.
  • To synthesize evidence from RCTs on statin use following percutaneous coronary intervention (PCI).

Main Methods:

  • A meta-analysis of six RCTs involving 2979 patients was performed.
  • Data were sourced from Medline reports up to October 2009.
  • Random effect models were used to calculate pooled risk ratios.

Main Results:

  • Post-PCI statin therapy significantly decreased the risk of repeat revascularization (RR=0.73, p=0.04).
  • Trends suggested decreased risks for all-cause mortality (RR=0.88) and myocardial infarction (MI) (RR=0.76), though not statistically significant.
  • Target lesion or vessel revascularization risk was also reduced (RR=0.58), but not significantly.

Conclusions:

  • Statin therapy initiated after PCI is associated with a reduced risk of repeat revascularization.
  • Further investigation is warranted to elucidate the underlying mechanisms of statin's efficacy post-PCI.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...